Rivaroxaban Decreases Risk for Thrombotic Events in Patients With COVID-19
Researchers conducted a study to assess the effect of thromboprophylaxis with rivaroxaban following hospital discharge in patients with COVID-19.
General Pulmonology
Safety and Risks Associated With Midline vs Peripherally Inserted Central Catheters
Researchers conducted a study to compare outcomes among patients who underwent placement of either a midline or peripherally inserted central catheter due to either difficult vascular access or to receive antibiotic therapy.
Implications of Declining Asthma Exacerbation Rates During the COVID-19 Pandemic
Asthma exacerbations dropped during the pandemic; what can be learned from this occurrence that may help lower exacerbation rates in the future?
Outcomes of Positive Expiratory Pressure Flute Therapy in Adults With COVID-19
Investigators conducted a study to determine whether positive expiratory pressure flute self-care decreases the risk for respiratory symptoms in adults recently diagnosed with SARS-CoV-2 infection.
Convalescent Plasma and Progression to Respiratory Failure/Death in COVID-19
Does convalescent plasma prevent worsening respiratory failure or death in patients with COVID-19 pneumonia?
Using Pneumonia Severity Index and CURB-65 to Predict COVID-19 Pneumonia Deaths
Are CURB-65 and PSI effective predictors of inpatient COVID-19 mortality, and would added measures for d-dimer and procalcitonin improve their predictive value?
Risk to Healthcare Workers From Use of CPAP, High Flow Nasal O2 for COVID-19?
Does use of CPAP or high-flow nasal oxygen by inpatients with COVID-19 expose nearby healthcare workers to a greater risk of viral contamination?
Effects of β-Lactam Plus Doxycycline in Older Adults With Community-Acquired Pneumonia
Researchers conducted a study to assess the effect of doxycycline treatment on the risk for 30 and 90-day all-cause mortality in older adults hospitalized with community-acquired pneumonia.
Ciclesonide May Be Promising Outpatient Therapy for Early COVID-19
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Optimal Dosing of Rifampicin/Isoniazid/Pyrazinamide in Children With Tuberculosis
Investigators conducted a study to determine the optimal fixed-dose combination of rifampicin/isoniazid/pyrazinamide in children with tuberculosis infection.
- Loading...
Loading...
Next post in Pediatric Illnesses
Loading... 
Loading...